LEVETIRACETAM Side Effects

7026370-6 | Anxiety, Delusion Of Reference, Headache, Hyperacusis, Hypoaesthesia, Ideas Of Reference
on Sep 22, 2010 Female patient from JAPAN , weighting 103.8 lb, was diagnosed with partial seizures and was treated with Levetiracetam (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), delusion of reference, headache (What is headache?), hyperacusis, hypoaesthesia, ideas of reference. Levetiracetam dosage: 500 Mg Bid Oral, 1000 Mg Bid Oral, 1500 Mg Bid Oral. During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), TELESMIN (View Telesmin Review and Telesmin Label ). Patient was hospitalized.

7023539-1 | Convulsion
Patient was taking Levetiracetam (View Usage). Patient had the following side effects: convulsion on Sep 30, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 125.0 lb, . Levetiracetam dosage: 500mg Qd Oral.

7019618-5 | Convulsion, Product Substitution Issue
Adverse event was reported on Sep 28, 2010 by a Female patient taking Levetiracetam (View Usage) (Dosage: 500 Mg Qd Oral) . Location: UNITED STATES , weighting 125.0 lb, After Levetiracetam was administered, patient had the following side effects: convulsion, product substitution issue.

7018683-9 | Abasia, Abnormal Behaviour, Condition Aggravated, Gait Disturbance, Mental Retardation, Partial Seizures
on Sep 23, 2010 Female patient from ARGENTINA , child 8 years of age, was diagnosed with convulsion and was treated with Levetiracetam (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, abnormal behaviour, condition aggravated, gait disturbance, mental retardation, partial seizures. Levetiracetam dosage: 1500 Mg;qd. During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ).


7018677-3 | Abnormal Behaviour, Condition Aggravated, Febrile Convulsion, Grand Mal Convulsion, Mental Retardation, Speech Disorder
on Sep 23, 2010 Male patient from ARGENTINA , child 4. years of age, was diagnosed with convulsion and was treated with Levetiracetam (View Usage). Patient had the following side effects: abnormal behaviour, condition aggravated, febrile convulsion, grand mal convulsion, mental retardation, speech disorder. Levetiracetam dosage: 1000 Mg;qd. During the same period patient was treated with CLOBAZAM (View Clobazam Review and Clobazam Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ).

7018267-2 | Confusional State, Decreased Appetite, Disorientation, Fall, Headache, Hypersomnia, Inappropriate Antidiuretic Hormone Secretion, Irritability, Major Depression
Patient was taking Levetiracetam (View Usage). After Levetiracetam was administered, patient had the following side effects: confusional state, decreased appetite, disorientation, fall (What is fall?), headache (What is headache?), hypersomnia, inappropriate antidiuretic hormone secretion, irritability, major depression on Sep 10, 2010 from SPAIN Additional patient health information: Female patient , 65 years of age, was diagnosed with nervous system disorder and. Levetiracetam dosage: (250 Mg Tid Oral). During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ). Patient was hospitalized.

7008068-3 | Psychotic Disorder, Tardive Dyskinesia
Adverse event was reported on Sep 17, 2010 by a Female patient taking Levetiracetam (View Usage) (Dosage: 1000 Mg) was diagnosed with tardive dyskinesia, schizophrenia, paranoid type and. Location: , 61 years of age, Patient experienced the following unwanted or unexpected effects: psychotic disorder (What is psychotic disorder?), tardive dyskinesia. During the same period patient was treated with RISPERIDONE (4 Mg) (View Risperidone Review and Risperidone Label ), BIPERIDEN HYDROCHLORIDE TAB (2 Mg) (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ), QUETIAPINE (25 Mg) (View Quetiapine Review and Quetiapine Label ).

7006340-4 | Convulsion, Electroencephalogram Abnormal, Myoclonus
on Sep 08, 2010 Female patient from CANADA , child 10 years of age, was treated with Levetiracetam (View Usage). Patient had the following side effects: convulsion, electroencephalogram abnormal, myoclonus. Levetiracetam dosage: 1500 Mg, Daily.

7006337-4 | Convulsion, Electroencephalogram Abnormal, Myoclonus
on Sep 08, 2010 Male patient from CANADA , child 4 years of age, was treated with Levetiracetam (View Usage). After Levetiracetam was administered, patient had the following side effects: convulsion, electroencephalogram abnormal, myoclonus. Levetiracetam dosage: 1000 Mg, Daily.

7005222-1 | Alopecia, Apathy, Contusion, Coordination Abnormal, Dark Circles Under Eyes, Dyspnoea, Fatigue, Imprisonment, Muscle Twitching
Patient was taking Levetiracetam (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, apathy, contusion, coordination abnormal, dark circles under eyes, dyspnoea, fatigue, imprisonment, muscle twitching on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 180.0 lb, was diagnosed with epilepsy (What is epilepsy?) and. Levetiracetam dosage: 500 Mg Capsule 1000mg Twice Daily Oral Early 2009.

6981353-7 | Delirium
Adverse event was reported on Aug 31, 2010 by a Female patient taking Levetiracetam (View Usage) (Dosage: ) was diagnosed with grand mal convulsion, hypertension, hypothyroidism, depression (What is depression?) and. Location: UNITED STATES , 80 years of age, Patient had the following side effects: delirium. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), TELMISARTAN (View Telmisartan Review and Telmisartan Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ). Patient was hospitalized.

6980140-3 | Brain Injury, Convulsion, Dizziness, Dyspnoea, Fatigue, Heart Rate Increased, Insomnia
on Sep 02, 2010 Female patient from UNITED STATES , 46 years of age, was diagnosed with convulsion and was treated with Levetiracetam (View Usage). After Levetiracetam was administered, patient had the following side effects: brain injury, convulsion, dizziness (What is dizziness?), dyspnoea, fatigue, heart rate increased, insomnia. Levetiracetam dosage: . During the same period patient was treated with MYSOLINE (View Mysoline Review and Mysoline Label ), DIAMOX SRC (Taken For Years) (View Diamox Src Review and Diamox Src Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ).

6979453-0 | Atrial Fibrillation, Cardiac Failure Congestive, Delirium
on Sep 08, 2010 Female patient from , 80 years of age, was diagnosed with grand mal convulsion, hypertension, depression (What is depression?) and was treated with Levetiracetam (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), cardiac failure congestive, delirium. Levetiracetam dosage: 2000 Mg. During the same period patient was treated with AMLODIPINE (10 Mg) (View Amlodipine Review and Amlodipine Label ), SERTRALINE (50 Mg) (View Sertraline Review and Sertraline Label ), RISPERIDONE (1 Mg) (View Risperidone Review and Risperidone Label ), FUROSEMIDE (20 Mg) (View Furosemide Review and Furosemide Label ), PHENYTOIN (1000 Mg) (View Phenytoin Review and Phenytoin Label ). Patient was hospitalized.

6974689-7 | Convulsion
Patient was taking Levetiracetam (View Usage). Patient had the following side effects: convulsion on Sep 09, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 22.05 lb, was diagnosed with convulsion, tuberous sclerosis (What is tuberous sclerosis?) and. Levetiracetam dosage: 100mg/1ml.

6974683-6 | Aggression, Dystonia, Feeling Abnormal, Verbal Abuse
Adverse event was reported on Sep 09, 2010 by a Male patient taking Levetiracetam (View Usage) (Dosage: 500 Mg Q12 Iv; 750 Mg Q 12 Iv) was diagnosed with convulsion and. Location: UNITED STATES , 15 years of age, weighting 132.3 lb, After Levetiracetam was administered, patient had the following side effects: aggression, dystonia (What is dystonia?), feeling abnormal, verbal abuse. Patient was hospitalized.

6974559-4 | Convulsion, Depressed Level Of Consciousness, Head Injury, Homicidal Ideation, Suicidal Ideation, Verbal Abuse
on Sep 09, 2010 Male patient from UNITED STATES , child 7 years of age, weighting 56.88 lb, was diagnosed with convulsion and was treated with Levetiracetam (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, depressed level of consciousness, head injury, homicidal ideation, suicidal ideation, verbal abuse. Levetiracetam dosage: 150 Mg Bid Po. Patient was hospitalized.

6968313-7 | Activities Of Daily Living Impaired, Delirium
on Aug 24, 2010 Female patient from UNITED STATES , 80 years of age, was diagnosed with grand mal convulsion and was treated with Levetiracetam (View Usage). Patient had the following side effects: activities of daily living impaired, delirium. Levetiracetam dosage: 1000 Mg, 2 In 1 D, Per Oral. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), TELMISARTAN (View Telmisartan Review and Telmisartan Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ). Patient was hospitalized.

6961129-7 | Condition Aggravated, Convulsion, Phenylketonuria
Patient was taking Levetiracetam (View Usage). After Levetiracetam was administered, patient had the following side effects: condition aggravated, convulsion, phenylketonuria (What is phenylketonuria?) on Aug 25, 2010 from TURKEY Additional patient health information: Female patient , 20 years of age, was diagnosed with convulsion and. Levetiracetam dosage: 1000 - 2000 Mg, Daily. Patient was hospitalized.

6947471-4 | Blood Thyroid Stimulating Hormone Decreased, Cardiac Failure Congestive, Delirium, Depressed Level Of Consciousness, Disturbance In Attention, Hyperthyroidism, Impaired Self-care, Poverty Of Thought Content
Adverse event was reported on Aug 10, 2010 by a Female patient taking Levetiracetam (View Usage) (Dosage: 1000 Mg; Bid;) . Location: UNITED STATES , 80 years of age, Patient experienced the following unwanted or unexpected effects: blood thyroid stimulating hormone decreased, cardiac failure congestive, delirium, depressed level of consciousness, disturbance in attention, hyperthyroidism, impaired self-care, poverty of thought content. During the same period patient was treated with AMIODARONE HYDROCHLORIDE (400 Mg; Bid; Po, 200 Mg; Qd;) (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), TELMISARTAN (View Telmisartan Review and Telmisartan Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ). Patient was hospitalized.

6941441-8 | Condition Aggravated
on Aug 23, 2010 Female patient from , 20 years of age, was diagnosed with grand mal convulsion and was treated with Levetiracetam (View Usage). Patient had the following side effects: condition aggravated. Levetiracetam dosage: 1000 Mg. Patient was hospitalized.

6939472-7 | Vomiting
on Jul 22, 2010 Female patient from ITALY , 63 years of age, was diagnosed with myoclonus and was treated with Levetiracetam (View Usage). After Levetiracetam was administered, patient had the following side effects: vomiting. Levetiracetam dosage: 500 Mg/ 2xday/ Intravenous; Loaded In 20 Minutes.

6939291-1 | Alopecia, Vitamin D Deficiency
Patient was taking Levetiracetam (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, vitamin d deficiency on Jul 28, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, was diagnosed with grand mal convulsion and. Levetiracetam dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ).

6939290-X | Photosensitivity Reaction, Pruritus, Urticaria
Adverse event was reported on Jul 16, 2010 by a Male patient taking Levetiracetam (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?), blood pressure increased and. Location: UNITED STATES , 38 years of age, weighting 200.0 lb, Patient had the following side effects: photosensitivity reaction, pruritus, urticaria. During the same period patient was treated with DILANTIN (View Dilantin Review and Dilantin Label ), DIOVAN (View Diovan Review and Diovan Label ).

6939289-3 | Headache, Petit Mal Epilepsy
on Jun 22, 2010 Female patient from UNITED STATES , 37 years of age, was diagnosed with grand mal convulsion and was treated with Levetiracetam (View Usage). After Levetiracetam was administered, patient had the following side effects: headache (What is headache?), petit mal epilepsy. Levetiracetam dosage: .

6939288-1 | Epileptic Aura
on May 20, 2010 Female patient from UNITED STATES , 63 years of age, weighting 170.0 lb, was diagnosed with convulsion and was treated with Levetiracetam (View Usage). Patient experienced the following unwanted or unexpected effects: epileptic aura. Levetiracetam dosage: . During the same period patient was treated with IRON (View Iron Review and Iron Label ), CLARITIN /00917501/ (View Claritin /00917501/ Review and Claritin /00917501/ Label ), VITAMINS (View Vitamins Review and Vitamins Label ).

6939287-X | Convulsion
Patient was taking Levetiracetam (View Usage). Patient had the following side effects: convulsion on Jun 18, 2010 from UNITED STATES Additional patient health information: Female patient , 42 years of age, weighting 359.4 lb, was diagnosed with convulsion, epilepsy (What is epilepsy?) and. Levetiracetam dosage: . During the same period patient was treated with CALCIUM (View Calcium Review and Calcium Label ).

6938522-1 | Convulsion, Product Substitution Issue
Adverse event was reported on Aug 09, 2010 by a Female patient taking Levetiracetam (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?) and. Location: AUSTRALIA , 71 years of age, After Levetiracetam was administered, patient had the following side effects: convulsion, product substitution issue. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), LAMOGINE (View Lamogine Review and Lamogine Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), NEXIUM (View Nexium Review and Nexium Label ), ACTONEL WITH CALCIUM (COPACKAGED) (View Actonel With Calcium (copackaged) Review and Actonel With Calcium (copackaged) Label ), DITROPAN (View Ditropan Review and Ditropan Label ).

6936458-3 | Depression, Dizziness
on Aug 09, 2010 Female patient from UNITED STATES , weighting 149.9 lb, was diagnosed with convulsion and was treated with Levetiracetam (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), dizziness (What is dizziness?). Levetiracetam dosage: (4000 Mg, 4000mg Total 1500mg In Am And Pm, And 1000mg At Noon Oral). During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), LACOSAMIDE (View Lacosamide Review and Lacosamide Label ), CLARITIN /00917501/ (View Claritin /00917501/ Review and Claritin /00917501/ Label ), DECADRON (View Decadron Review and Decadron Label ), PEPCID (View Pepcid Review and Pepcid Label ), BENADRYL (View Benadryl Review and Benadryl Label ), DILANTIN (View Dilantin Review and Dilantin Label ).

6936457-1 | Abdominal Discomfort, Diarrhoea, Incorrect Dose Administered
on Aug 06, 2010 Female patient from UNITED STATES , weighting 103.0 lb, was diagnosed with convulsion and was treated with Levetiracetam (View Usage). Patient had the following side effects: abdominal discomfort, diarrhoea, incorrect dose administered. Levetiracetam dosage: (2500 Mg, 1000 Mg Am/1500 Mg Pm Oral). During the same period patient was treated with ZARONTIN (View Zarontin Review and Zarontin Label ).

6934226-X | Mucosal Haemorrhage, Thrombocytopenia
Patient was taking Levetiracetam (View Usage). After Levetiracetam was administered, patient had the following side effects: mucosal haemorrhage, thrombocytopenia on Aug 17, 2010 from Additional patient health information: Male patient , child 6 years of age, was diagnosed with convulsion and. Levetiracetam dosage: 1000 Mg. During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), HEPARIN (View Heparin Review and Heparin Label ), WARFARIN (View Warfarin Review and Warfarin Label ).

6931135-7 | Aggression, Mental Status Changes
Adverse event was reported on Aug 17, 2010 by a Male patient taking Levetiracetam (View Usage) (Dosage: 500mg Q12 Hours Iv) was diagnosed with convulsion prophylaxis and. Location: UNITED STATES , 75 years of age, weighting 196.2 lb, Patient experienced the following unwanted or unexpected effects: aggression, mental status changes. Patient was hospitalized.

6921703-0 | Brain Injury, Convulsion, Dizziness, Dyspnoea, Fatigue, Heart Rate Increased, Insomnia
on Aug 05, 2010 Female patient from UNITED STATES , 46 years of age, was diagnosed with convulsion and was treated with Levetiracetam (View Usage). Patient had the following side effects: brain injury, convulsion, dizziness (What is dizziness?), dyspnoea, fatigue, heart rate increased, insomnia. Levetiracetam dosage: . During the same period patient was treated with MYSOLINE (View Mysoline Review and Mysoline Label ), DIAMOX SRC (Taken For Years) (View Diamox Src Review and Diamox Src Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ).

6919820-4 | Fall, Hypoaesthesia, Muscular Weakness, Oedema, Pain
on Aug 10, 2010 Female patient from UNITED STATES , weighting 130.7 lb, was diagnosed with convulsion and was treated with Levetiracetam (View Usage). After Levetiracetam was administered, patient had the following side effects: fall (What is fall?), hypoaesthesia, muscular weakness, oedema, pain (What is pain?). Levetiracetam dosage: . Patient was hospitalized.

6918098-5 | Condition Aggravated, Grand Mal Convulsion
Patient was taking Levetiracetam (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, grand mal convulsion on Jul 26, 2010 from TURKEY Additional patient health information: Female patient , 20 years of age, was diagnosed with convulsion and. Levetiracetam dosage: 1000 Mg;per Day ; 1500 Mg;per Day ; 2000 Mg;per Day. Patient was hospitalized.

6915696-X | Confusional State, Depressed Level Of Consciousness, Disorientation, Fall, Inappropriate Antidiuretic Hormone Secretion, Major Depression, Sensory Loss
Adverse event was reported on Dec 16, 2009 by a Female patient taking Levetiracetam (View Usage) (Dosage: 250 Mg Tid Oral) was diagnosed with nervous system disorder and. Location: SPAIN , 65 years of age, Patient had the following side effects: confusional state, depressed level of consciousness, disorientation, fall (What is fall?), inappropriate antidiuretic hormone secretion, major depression, sensory loss. During the same period patient was treated with ENALAPRIL (View Enalapril Review and Enalapril Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ). Patient was hospitalized.

6914413-7 | Thrombocytopenia
on Jul 30, 2010 Male patient from UNITED KINGDOM , child 6 years of age, was diagnosed with cerebral venous thrombosis and was treated with Levetiracetam (View Usage). After Levetiracetam was administered, patient had the following side effects: thrombocytopenia. Levetiracetam dosage: 500 Mg Tid.

6909194-7 | Bradyphrenia, Hypokinesia, Sedation, Somnolence
on Aug 02, 2010 Female patient from , 46 years of age, was diagnosed with convulsion and was treated with Levetiracetam (View Usage). Patient experienced the following unwanted or unexpected effects: bradyphrenia, hypokinesia, sedation, somnolence. Levetiracetam dosage: 1000 Mg. During the same period patient was treated with TOPIRAMATE (100 Mg) (View Topiramate Review and Topiramate Label ), FEXOPHENADINE (View Fexophenadine Review and Fexophenadine Label ).

6908247-7 | Haemoglobin Decreased, Petechiae, Thrombocytopenia, White Blood Cell Count Decreased
Patient was taking Levetiracetam (View Usage). Patient had the following side effects: haemoglobin decreased, petechiae, thrombocytopenia, white blood cell count decreased on Jul 26, 2010 from UNITED STATES Additional patient health information: Male patient , 35 years of age, was diagnosed with partial seizures, hiv test positive (What is hiv test positive?) and. Levetiracetam dosage: (500 Mg Bid Oral), (1500 Mg Bid Oral).

6887216-X | Mydriasis
Adverse event was reported on Jul 22, 2010 by a Male patient taking Levetiracetam (View Usage) (Dosage: ) was diagnosed with convulsion and. Location: , weighting 55.12 lb, After Levetiracetam was administered, patient had the following side effects: mydriasis.

6882073-X | Convulsion, Fatigue, Heart Rate Increased
on Jul 19, 2010 Female patient from UNITED STATES , 46 years of age, was diagnosed with convulsion and was treated with Levetiracetam (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, fatigue, heart rate increased. Levetiracetam dosage: . During the same period patient was treated with MYSOLINE (View Mysoline Review and Mysoline Label ), DIAMOX SRC (Taken For Years) (View Diamox Src Review and Diamox Src Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ).

6872262-2 | Insomnia, Mood Altered, Neck Pain
on Jul 07, 2010 Female patient from , 86 years of age, was treated with Levetiracetam (View Usage). Patient had the following side effects: insomnia, mood altered, neck pain. Levetiracetam dosage: .

6863001-X | Anxiety, Delusion Of Reference, Headache, Hyperacusis, Hypoaesthesia, Ideas Of Reference
Patient was taking Levetiracetam (View Usage). After Levetiracetam was administered, patient had the following side effects: anxiety (What is anxiety?), delusion of reference, headache (What is headache?), hyperacusis, hypoaesthesia, ideas of reference on Jul 07, 2010 from JAPAN Additional patient health information: Female patient , weighting 103.8 lb, was diagnosed with partial seizures and. Levetiracetam dosage: (500 Mg Bid Oral), (1000 Mg Bid Oral), (1500 Mg Bid Oral). During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ). Patient was hospitalized.

6862707-6 | Abasia, Abnormal Behaviour, Condition Aggravated, Convulsion, Encephalopathy, Gait Disturbance, Myoclonus
Adverse event was reported on Jul 08, 2010 by a Female patient taking Levetiracetam (View Usage) (Dosage: 1500 Mg) was diagnosed with partial seizures and. Location: ARGENTINA , child 10 years of age, weighting 77.16 lb, Patient experienced the following unwanted or unexpected effects: abasia, abnormal behaviour, condition aggravated, convulsion, encephalopathy, gait disturbance, myoclonus. During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ).

6862367-4 | Clonic Convulsion, Gait Disturbance, Head Titubation, Therapeutic Agent Toxicity, Vomiting
on Jul 05, 2010 Male patient from JAPAN , weighting 191.8 lb, was diagnosed with partial seizures, epilepsy (What is epilepsy?) and was treated with Levetiracetam (View Usage). Patient had the following side effects: clonic convulsion, gait disturbance, head titubation, therapeutic agent toxicity, vomiting. Levetiracetam dosage: (500 Mg Bid Oral), (1000 Mg Bid Oral), (1500 Mg Bid Oral). During the same period patient was treated with PHENYTOIN ((2.4 G Qd Oral)) (View Phenytoin Review and Phenytoin Label ), ALEVIATIN /00017401/ (ALEVIATIN) ((200 Mg Qd Oral)) (View Aleviatin /00017401/ (aleviatin) Review and Aleviatin /00017401/ (aleviatin) Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), IMIDAPRIL HYDROCHLORIDE (View Imidapril Hydrochloride Review and Imidapril Hydrochloride Label ). Patient was hospitalized.

6861466-0 | Convulsion, Off Label Use
on Jul 07, 2010 Female patient from ITALY , 91 years of age, was diagnosed with status epilepticus and was treated with Levetiracetam (View Usage). After Levetiracetam was administered, patient had the following side effects: convulsion, off label use. Levetiracetam dosage: (2000 Mg Load And 3000 Mg Daily Maintenance Intravenous (not Otherwise Specified). During the same period patient was treated with BETAMETHASONE (View Betamethasone Review and Betamethasone Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), MANNITOL (View Mannitol Review and Mannitol Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), OXYGEN (View Oxygen Review and Oxygen Label ).

6861428-3 | Abnormal Behaviour, Convulsion, Grand Mal Convulsion, Myoclonus, Petit Mal Epilepsy, Pyrexia, Status Epilepticus, Thrombocytopenia
Patient was taking Levetiracetam (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, convulsion, grand mal convulsion, myoclonus, petit mal epilepsy, pyrexia, status epilepticus, thrombocytopenia on Jul 08, 2010 from ARGENTINA Additional patient health information: Male patient , child 9 years of age, . Levetiracetam dosage: (1000 Mg). During the same period patient was treated with CLOBAZAM (CLOBAZAM) (View Clobazam (clobazam) Review and Clobazam (clobazam) Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ).

6860921-7 | Bradykinesia, Cognitive Disorder, Dermatitis, No Therapeutic Response, Rash Macular, Rash Pruritic, Sedation
Adverse event was reported on Jun 30, 2010 by a Female patient taking Levetiracetam (View Usage) (Dosage: 500 Mg; Bid; 1000 Mg;bid; 250 Mg;q12h; 500 Mg;q12h; 750 Mg;q12h) was diagnosed with convulsion and. Location: UNITED STATES , 46 years of age, Patient had the following side effects: bradykinesia, cognitive disorder, dermatitis, no therapeutic response, rash macular, rash pruritic, sedation. During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

6858002-1 | Abnormal Behaviour, Anxiety, Convulsion, Dizziness, Increased Appetite, Product Substitution Issue, Psychomotor Hyperactivity, Rash
on Jul 19, 2010 Male patient from UNITED STATES , child 3 years of age, weighting 61.29 lb, was diagnosed with convulsion and was treated with Levetiracetam (View Usage). After Levetiracetam was administered, patient had the following side effects: abnormal behaviour, anxiety (What is anxiety?), convulsion, dizziness (What is dizziness?), increased appetite, product substitution issue, psychomotor hyperactivity, rash (What is rash?). Levetiracetam dosage: 100mg/ml - 5ml Po Bid.

6857132-8 | Abasia, Abnormal Behaviour, Convulsion, Gait Disturbance, Myoclonus
on Jul 08, 2010 Female patient from ARGENTINA , child 10 years of age, was treated with Levetiracetam (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, abnormal behaviour, convulsion, gait disturbance, myoclonus. Levetiracetam dosage: 1500mg Per Day. During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ).

6829765-6 | Bronchitis, Immobile, Locked-in Syndrome, Myoclonus, Neuropathy Peripheral, Pneumonia, Pyrexia, Respiratory Failure, Speech Disorder
Patient was taking Levetiracetam (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), immobile, locked-in syndrome, myoclonus, neuropathy peripheral, pneumonia (What is pneumonia?), pyrexia, respiratory failure, speech disorder on Jun 24, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 150.4 lb, was diagnosed with convulsion and. Levetiracetam dosage: 750 Mg Bid, Started 2 Years Ago Oral), (1000mg Bid), (500mg Bid). Patient was hospitalized.